Biotech

Carterra HT-SPR Helps Turn Anthropic’s Autonomous Protein Design Into Measurable Results

Carterra’s high-throughput SPR platforms help validate 1,320 AI-designed protein binders across 15 targets, highlighting the growing role of rapid experimental data in AI-driven drug discovery.

Hummingbird Bioscience wins APAC AI Discovery Award

Singapore-based Hummingbird Bioscience has been named the Asia Pacific Trailblazer Award winner at the 2026 Nebius AI Discovery Awards, recognising the company's AI-first approach to therapeutic discovery and development.

Tecan Brings Agentic AI to the Lab Bench with NVIDIA-powered Introspect Upgrade

New capabilities aim to shift laboratories from reactive troubleshooting to proactive problem-solving, but the real test will be whether AI agents can earn scientists' trust.

Moving research out of the lab is key to UK life science success

Professor Chris Day explores why strengthening university commercialisation and supporting spinouts will be critical to securing the UK's position as a global life sciences leader.

Laverock Therapeutics Advances CAR-T and Macrophage Programmes with Solid Tumour Data

In-vivo results from both oncology programmes support lead candidate selection, as the UK biotech charts a path toward clinical trials.

UK Biotech Cyclana Bio is Trying to Understand Endometriosis From the Tissue Up

Cyclana Bio's PEMP study has received NHS ethics approval and begun enrolling women at two UK hospitals. If its tissue-first approach to drug discovery pays off, it could start answering questions that have gone unanswered for decades.